Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 111051-111100 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03104842
Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone
PHASE2
Active, not recruiting
246 participants
Started: Aug 15, 2017 · Completed: Sep 30, 2026
1 condition
1 sponsor
17 locations
NCT03016819
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
PHASE3
Active, not recruiting
325 participants
Started: Aug 15, 2017 · Completed: Jun 30, 2025
4 conditions
1 sponsor
23 locations
NCT05066113
Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin
NA
Recruiting
50 participants
Started: Aug 15, 2017 · Completed: Aug 31, 2028
2 conditions
1 sponsor
1 location
NCT03179553
Heart Beat Variability in Neonatal Encephalopathy
N/A
Active, not recruiting
210 participants
Started: Aug 15, 2017 · Completed: Nov 28, 2025
3 conditions
1 sponsor
5 locations
NCT03252938
Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors
PHASE1
Recruiting
110 participants
Started: Aug 15, 2017 · Completed: Sep 30, 2025
4 conditions
2 sponsors
12 locations
NCT03226704
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
N/A
Enrolling by invitation
120 participants
Started: Aug 14, 2017 · Completed: Jul 31, 2030
5 conditions
1 sponsor
1 location
NCT03264261
Constraint Induced Movement Therapy for Walking in Individuals Post Stroke
NA
Recruiting
36 participants
Started: Aug 14, 2017 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT02932501
Medication-related Osteonecrosis of the Jaw (MRONJ) Registry
N/A
Active, not recruiting
518 participants
Started: Aug 14, 2017 · Completed: Apr 30, 2024
2 conditions
2 sponsors
14 locations
NCT04008407
ESD for Colorectal LSL Using a Selective Strategy - a Prospective Cohort Study
NA
Recruiting
391 participants
Started: Aug 14, 2017 · Completed: Feb 29, 2028
2 conditions
1 sponsor
1 location
NCT03080974
Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
PHASE2
Recruiting
10 participants
Started: Aug 14, 2017 · Completed: Apr 1, 2026
1 condition
1 sponsor
1 location
NCT02888743
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
110 participants
Started: Aug 14, 2017 · Completed: Jan 2, 2026
6 conditions
1 sponsor
42 locations
NCT03313778
Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors
PHASE1
Recruiting
242 participants
Started: Aug 14, 2017 · Completed: Aug 1, 2027
1 condition
2 sponsors
34 locations
NCT03202316
Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer
PHASE2
Active, not recruiting
37 participants
Started: Aug 11, 2017 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT03146078
Rate of Progression in USH2A-related Retinal Degeneration
N/A
Active, not recruiting
127 participants
Started: Aug 11, 2017 · Completed: Dec 31, 2029
2 conditions
2 sponsors
16 locations
NCT03109288
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
PHASE1/PHASE2
Recruiting
250 participants
Started: Aug 11, 2017 · Completed: Jan 1, 2029
1 condition
1 sponsor
1 location
NCT02893917
Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer
PHASE2
Active, not recruiting
90 participants
Started: Aug 11, 2017 · Completed: Jun 18, 2026
6 conditions
1 sponsor
16 locations
NCT03118986
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy
PHASE2
Recruiting
200 participants
Started: Aug 10, 2017 · Completed: Apr 30, 2026
4 conditions
9 sponsors
10 locations
NCT03291756
CorEvitas Multiple Sclerosis (MS) Registry
N/A
Enrolling by invitation
1,000 participants
Started: Aug 10, 2017 · Completed: Dec 31, 2100
1 condition
1 sponsor
1 location
NCT02910557
Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection
N/A
Recruiting
300 participants
Started: Aug 10, 2017 · Completed: Jan 7, 2038
2 conditions
1 sponsor
23 locations
NCT03719339
VIRTUUS Children's Study
N/A
Active, not recruiting
445 participants
Started: Aug 10, 2017 · Completed: Aug 31, 2025
7 conditions
2 sponsors
13 locations
NCT03089905
A Study to Compare the Long-term Outcomes After Two Different Anaesthetics
PHASE3
Active, not recruiting
450 participants
Started: Aug 10, 2017 · Completed: Jun 30, 2026
3 conditions
13 sponsors
21 locations
NCT03215836
Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics
NA
Recruiting
50 participants
Started: Aug 10, 2017 · Completed: Dec 31, 2029
3 conditions
2 sponsors
1 location
NCT03192397
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
PHASE1/PHASE2
Active, not recruiting
35 participants
Started: Aug 9, 2017 · Completed: May 21, 2027
13 conditions
1 sponsor
1 location
NCT03248310
A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management
N/A
Recruiting
600 participants
Started: Aug 9, 2017 · Completed: Aug 31, 2026
1 condition
1 sponsor
3 locations
NCT02295059
Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention
NA
Active, not recruiting
80 participants
Started: Aug 9, 2017 · Completed: Jun 22, 2026
1 condition
2 sponsors
2 locations
NCT03234296
Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis
NA
Enrolling by invitation
147 participants
Started: Aug 9, 2017 · Completed: Aug 30, 2029
1 condition
5 sponsors
1 location
NCT03136146
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
PHASE2
Recruiting
42 participants
Started: Aug 9, 2017 · Completed: Aug 1, 2027
11 conditions
2 sponsors
1 location
NCT03114462
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
PHASE1
Recruiting
11 participants
Started: Aug 9, 2017 · Completed: Jun 1, 2027
2 conditions
2 sponsors
1 location
NCT03226158
Next Generation Pathogen Sequencing for Prediction of Adverse Events
N/A
Active, not recruiting
160 participants
Started: Aug 9, 2017 · Completed: Mar 1, 2026
1 condition
2 sponsors
1 location
NCT03007147
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
PHASE3
Active, not recruiting
475 participants
Started: Aug 8, 2017 · Completed: Sep 30, 2027
4 conditions
3 sponsors
226 locations
NCT03300141
Looking Glass: Bimanual Balanced Reaching With Visual Biofeedback
NA
Enrolling by invitation
75 participants
Started: Aug 8, 2017 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT03114527
Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)
PHASE2
Active, not recruiting
48 participants
Started: Aug 8, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT03383445
Transcatheter Aortic Valve Replacement Versu Surgical Aortix Valve Replacement for Treating Elderly Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Prospective Randomized Study The VIVA Trial
NA
Active, not recruiting
300 participants
Started: Aug 8, 2017 · Completed: May 30, 2024
3 conditions
1 sponsor
1 location
NCT03328650
Clinical Outcomes of the ALPS Proximal Humerus Plating System
N/A
Recruiting
150 participants
Started: Aug 7, 2017 · Completed: Dec 1, 2031
1 condition
1 sponsor
1 location
NCT03026816
Epidural Stimulation After Neurologic Damage
NA
Recruiting
100 participants
Started: Aug 7, 2017 · Completed: Jan 31, 2028
2 conditions
5 sponsors
1 location
NCT06262958
Recognition and Early Intervention for Alcohol and Substance Abuse in Adolescence in Adolescent
NA
Recruiting
800 participants
Started: Aug 7, 2017 · Completed: Jun 1, 2030
7 conditions
1 sponsor
1 location
NCT03244995
Mind-Body Intervention in Glioma Couples
NA
Active, not recruiting
74 participants
Started: Aug 6, 2017 · Completed: Dec 31, 2025
6 conditions
2 sponsors
1 location
NCT03160079
Blinatumomab and Pembrolizumab for Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia With High Marrow Lymphoblasts
PHASE1/PHASE2
Active, not recruiting
16 participants
Started: Aug 4, 2017 · Completed: Dec 31, 2025
1 condition
3 sponsors
4 locations
NCT03220477
Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.
PHASE1
Active, not recruiting
28 participants
Started: Aug 4, 2017 · Completed: Jul 31, 2026
1 condition
6 sponsors
3 locations
NCT03293173
Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis
PHASE2
Active, not recruiting
120 participants
Started: Aug 4, 2017 · Completed: Dec 31, 2024
1 condition
3 sponsors
16 locations
NCT02991690
Systemic Hypothermia in Acute Cervical Spinal Cord Injury
NA
Recruiting
120 participants
Started: Aug 4, 2017 · Completed: Sep 30, 2026
1 condition
2 sponsors
7 locations
NCT03245892
A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer
PHASE1
Active, not recruiting
40 participants
Started: Aug 4, 2017 · Completed: Aug 31, 2026
3 conditions
2 sponsors
1 location
NCT03495440
Families of Youth with Developmental Disabilities: a Theory-Based Intervention
NA
Recruiting
150 participants
Started: Aug 4, 2017 · Completed: Dec 31, 2024
3 conditions
1 sponsor
2 locations
NCT03162627
Selumetinib and Olaparib in Solid Tumors
PHASE1
Active, not recruiting
90 participants
Started: Aug 4, 2017 · Completed: Aug 30, 2026
5 conditions
2 sponsors
1 location
NCT03186118
Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia
PHASE1
Active, not recruiting
30 participants
Started: Aug 4, 2017 · Completed: Jul 31, 2033
1 condition
1 sponsor
1 location
NCT03702309
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
N/A
Recruiting
2,500 participants
Started: Aug 3, 2017 · Completed: Jul 6, 2025
18 conditions
1 sponsor
1 location
NCT03221036
Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis
PHASE3
Recruiting
402 participants
Started: Aug 3, 2017 · Completed: Jul 18, 2028
1 condition
1 sponsor
39 locations
NCT03206671
Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
PHASE3
Active, not recruiting
650 participants
Started: Aug 3, 2017 · Completed: Jun 30, 2027
1 condition
2 sponsors
88 locations
NCT03225677
Novel Tracer Methods to Evaluate Muscle Protein Metabolism in Cirrhosis
N/A
Recruiting
20 participants
Started: Aug 3, 2017 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT03181867
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
PHASE2
Enrolling by invitation
800 participants
Started: Aug 3, 2017 · Completed: Dec 31, 2030
5 conditions
1 sponsor
1 location
Previous
1
More pages
2219
2220
2221
2222
2223
2224
2225
More pages
2369
Next